The Use of Rivaroxaban in Patients With Atrial Fibrillation Receiving Hemodialysis-Antithrombotic Therapy for Atrial Fibrillation CHEST Guideline and Expert Panel Report Response

被引：0
|
作者：
Lip, Gregory Y. H. [1 ,2 ,3 ]
Ruff, Christian T. [4 ]
Moores, Lisa [5 ]
机构：
[1] Univ Liverpool, Liverpool Ctr Cardiovasc Sci, West Derby St, Liverpool L7 8TX, Merseyside, England
[2] Liverpool Heart & Chest Hosp, Liverpool, Merseyside, England
[3] Aalborg Univ, Aalborg Thrombosis Res Unit, Dept Clin Med, Aalborg, Denmark
[4] Harvard Med Sch, Cardiovasc Med Div, Brigham & Womens Hosp, Boston, MA 02115 USA
[5] Uniformed Serv Univ Hlth Sci, F Edward Hebert Sch Med, Bethesda, MD 20814 USA
来源：
CHEST | 2019年 / 155卷 / 06期
关键词：
D O I：
10.1016/j.chest.2019.02.329
中图分类号：
R4 [临床医学];
学科分类号：
1002 ; 100602 ;
摘要：
引用
收藏
页码：1307 / 1307
页数：1
相关论文
共 50 条
  • [1] The Use of Rivaroxaban in Patients With Atrial Fibrillation Receiving Hemodialysis-Antithrombotic Therapy for Atrial Fibrillation CHEST Guideline and Expert Panel Report
    Moore, Kenneth T.
    CHEST, 2019, 155 (06) : 1306 - 1307
  • [2] Antithrombotic Therapy for Atrial Fibrillation CHEST Guideline and Expert Panel Report
    Lip, Gregory Y. H.
    Banerjee, Amitava
    Boriani, Giuseppe
    Chiang, Chern en
    Fargo, Ramiz
    Freedman, Ben
    Lane, Deirdre A.
    Ruff, Christian T.
    Turakhia, Mintu
    Werring, David
    Patel, Sheena
    Moores, Lisa
    CHEST, 2018, 154 (05) : 1121 - 1201
  • [3] Dabigatran and Rivaroxaban Use in Atrial Fibrillation Patients on Hemodialysis
    Chan, Kevin E.
    Edelman, Elazer R.
    Wenger, Julia B.
    Thadhani, Ravi I.
    Maddux, Franklin W.
    CIRCULATION, 2015, 131 (11) : 972 - 979
  • [4] The New CHEST Guidelines on Antithrombotic Therapy for Atrial Fibrillation Should Consider Recent Data on Rivaroxaban Response
    Lip, Gregory Y. H.
    Ruff, Christian T.
    Moores, Lisa
    CHEST, 2019, 155 (06) : 1311 - 1312
  • [5] ATTAINMENT OF GUIDELINE RECOMMENDED ANTITHROMBOTIC THERAPY IN PATIENTS WITH NONVALVULAR ATRIAL FIBRILLATION
    Tellor, Katie B.
    Lloyd, Michael
    Armbruster, Anastasia
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2018, 71 (11) : 317 - 317
  • [6] Safety of apixaban and rivaroxaban in patients with atrial fibrillation on hemodialysis
    Ito, Hiroshi
    EUROPEAN JOURNAL OF INTERNAL MEDICINE, 2024, 124 : 154 - 155
  • [7] The New CHEST Guidelines on Antithrombotic Therapy for Atrial Fibrillation Should Consider Recent Data on Rivaroxaban
    Kim, Young-Hoon
    Shim, Jaemin
    Tsai, Chia-Ti
    Wang, Chun-Chieh
    Vilela, Gilbert
    Muengtaweepongsa, Sombat
    Kurniawan, Mohammad
    Maskon, Oteh
    Hsu, Li Fern
    Thang Huy Nguyen
    Sim, Kenneth
    Camm, A. John
    CHEST, 2019, 155 (06) : 1309 - 1311
  • [8] Antithrombotic therapy to prevent stroke in patients with atrial fibrillation -: In response
    Hart, RG
    Pearce, LA
    ANNALS OF INTERNAL MEDICINE, 2000, 132 (10) : 841 - 842
  • [9] Selecting antithrombotic therapy for patients with atrial fibrillation
    Tanaka-Esposito, Christine
    Chung, Mina K.
    CLEVELAND CLINIC JOURNAL OF MEDICINE, 2015, 82 (01) : 49 - 63
  • [10] Prevalence of Atrial Fibrillation and Antithrombotic Therapy in Hemodialysis Patients: Cross-Sectional Results of the Vienna InVestigation of AtriaL Fibrillation and Thromboembolismin Patients on HemoDIalysis (VIVALDI)
    Koenigsbruegge, Oliver
    Posch, Florian
    Antlanger, Marlies
    Kovarik, Josef
    Klauser-Braun, Renate
    Kletzmayr, Josef
    Schmaldienst, Sabine
    Auinger, Martin
    Zuntner, Guenther
    Lorenz, Matthias
    Grilz, Ella
    Stampfel, Gerald
    Steiner, Stefan
    Pabinger, Ingrid
    Saeemann, Marcus
    Ay, Cihan
    PLOS ONE, 2017, 12 (01):
12345